EU clears J&J’s $21B Synthes buyout | Wall Street Beat April 19, 2012 By MassDevice staff Leave a Comment Johnson & Johnson‘s (NYSE:JNJ) move to ditch its DePuy trauma business mollified EuroZone anti-trust regulators enough to win their approval for its $21.3 billion buyout of Synthes Inc.